n gonorrhoeae Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98
    ATCC n gonorrhoeae
    N Gonorrhoeae, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/n gonorrhoeae/product/ATCC
    Average 98 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    n gonorrhoeae - by Bioz Stars, 2021-03
    98/100 stars
      Buy from Supplier

    86
    Roche n gonorrhoeae
    Percent of non-empirically treated gyrA wild-type Neisseria <t>gonorrhoeae</t> cases treated with ciprofloxacin at UCLA Health between 1 January 2015 and 29 July 2016. Period 1 is the period before assay implementation (1 January 2015 – 31 October 2015), during which time there were no genotype results available. Period 2 is the initial seven months of assay implementation prior to sending electronic reminders of genotype results to providers (1 November 2015 – 26 May 2016). Period 3 is the final two months of assay implementation after electronic reminder notifications began (27 May 2016– 29 July 2016). *Electronic reminders began 27 May 2016
    N Gonorrhoeae, supplied by Roche, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/n gonorrhoeae/product/Roche
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    n gonorrhoeae - by Bioz Stars, 2021-03
    86/100 stars
      Buy from Supplier

    86
    Gen-Probe n gonorrhoeae
    C. trachomatis and N. <t>gonorrhoeae</t> infections missed by different screening practices. CT, C. trachomatis ; GC, N. gonorrhoeae .
    N Gonorrhoeae, supplied by Gen-Probe, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/n gonorrhoeae/product/Gen-Probe
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    n gonorrhoeae - by Bioz Stars, 2021-03
    86/100 stars
      Buy from Supplier

    99
    ATCC n gonorrhoeae atcc 49226
    C. trachomatis and N. <t>gonorrhoeae</t> infections missed by different screening practices. CT, C. trachomatis ; GC, N. gonorrhoeae .
    N Gonorrhoeae Atcc 49226, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/n gonorrhoeae atcc 49226/product/ATCC
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    n gonorrhoeae atcc 49226 - by Bioz Stars, 2021-03
    99/100 stars
      Buy from Supplier

    N/A
    Mouse Anti Neisseria gonorrhoeae 500 µg
      Buy from Supplier

    N/A
    Rabbit Anti N gonorrhoeae
      Buy from Supplier

    N/A
    Mouse Anti N gonorrhoeae MOMP 30kDa
      Buy from Supplier

    Image Search Results


    Percent of non-empirically treated gyrA wild-type Neisseria gonorrhoeae cases treated with ciprofloxacin at UCLA Health between 1 January 2015 and 29 July 2016. Period 1 is the period before assay implementation (1 January 2015 – 31 October 2015), during which time there were no genotype results available. Period 2 is the initial seven months of assay implementation prior to sending electronic reminders of genotype results to providers (1 November 2015 – 26 May 2016). Period 3 is the final two months of assay implementation after electronic reminder notifications began (27 May 2016– 29 July 2016). *Electronic reminders began 27 May 2016

    Journal: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

    Article Title: Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System

    doi: 10.1093/cid/ciw864

    Figure Lengend Snippet: Percent of non-empirically treated gyrA wild-type Neisseria gonorrhoeae cases treated with ciprofloxacin at UCLA Health between 1 January 2015 and 29 July 2016. Period 1 is the period before assay implementation (1 January 2015 – 31 October 2015), during which time there were no genotype results available. Period 2 is the initial seven months of assay implementation prior to sending electronic reminders of genotype results to providers (1 November 2015 – 26 May 2016). Period 3 is the final two months of assay implementation after electronic reminder notifications began (27 May 2016– 29 July 2016). *Electronic reminders began 27 May 2016

    Article Snippet: At UCLA, cases of N. gonorrhoeae are detected by the Cobas 4800 CT/NG assay (Roche Molecular Systems, Pleasanton, California).

    Techniques:

    C. trachomatis and N. gonorrhoeae infections missed by different screening practices. CT, C. trachomatis ; GC, N. gonorrhoeae .

    Journal: Journal of Clinical Microbiology

    Article Title: Extragenital Screening Is Essential for Comprehensive Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in the Pediatric Population

    doi: 10.1128/JCM.00335-19

    Figure Lengend Snippet: C. trachomatis and N. gonorrhoeae infections missed by different screening practices. CT, C. trachomatis ; GC, N. gonorrhoeae .

    Article Snippet: The positive and negative agreement for both C. trachomatis and N. gonorrhoeae was 100%; hence, the assay was deemed acceptable for C. trachomatis and N. gonorrhoeae testing in the oropharynx.

    Techniques: